GBAC BoardroomEducation has released its landmark research, Quantum Healthcare 2025: The Executive Blueprint, offering global leaders a strategic framework for harnessing Quantum Computing (QC) and Artificial Intelligence (AI) in drug discovery and precision medicine. Authored by Prof. Yusuf A. Azizullah and Dr. Aisha Rahim, MD, the study explores market trends, healthcare applications, governance models, and investment strategies. It highlights the IGRQ Nexus—GBAC’s proprietary governance-risk-investment framework—as essential for navigating this transformative era. The blueprint positions stakeholders to lead in a future where QC and AI will redefine global healthcare innovation, security, and equity.